Status:
COMPLETED
Pharmacogenetics of Nicotine Metabolism in African-Americans
Lead Sponsor:
University of California, San Francisco
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The investigators hypothesize that African Americans (AAs) smoke more for positive reinforcement from nicotine with a "peak-seeking" pattern of smoking (smoking individual cigarettes more intensively ...
Detailed Description
Smoking is the major preventable cause of cancer, premature cardiovascular disease and chronic obstructive lung disease, reproductive problems and infections. AA smokers have a substantially higher ri...
Eligibility Criteria
Inclusion
- African-American
- Age 18-65
- Smoke at least 5 cigarettes per day
Exclusion
- Significant health conditions
- Drug use
- Pregnancy or breastfeeding
- Inability to read English
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00879918
Start Date
December 1 2008
End Date
March 1 2012
Last Update
May 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco/SFGH
San Francisco, California, United States, 94110